Molecular Diagnostics

In The DNA: Shortcut to Identify Pathogens Found

Researchers have developed a new tool that could help provide early warnings of potentially deadly bacterial pathogens which cause sepsis, among other uses.

Molecular Diagnostics

Seegene, Bio-Rad Partner on Diagnostic Testing Products for U.S.

Seegene announced that it has signed a partnership with Bio-Rad for the development of infectious disease molecular diagnostic products.

Molecular Diagnostics

Quantgene Demonstrates Sequencing Precision in Scientific Journal

With accuracy exceeding 1 mutant in 1,000 wild type DNA fragments, the publication showcases the power of Quantgene’s new cloud and AI technology in cancer detection systems.

Oxford University, Prenetics Partner to Scale Rapid Testing Tech Globally

May 3, 2021 | Covid 19, Molecular Diagnostics

The University of Oxford, Prenetics, and the Oxford Suzhou Centre for Advanced Research have signed collaboration agreements to further develop the OxLAMP rapid, molecular testing technology for infectious diseases.

Isohelix, AutoGen Sign Agreement to Integrate DNA Extraction Workflows

Apr 29, 2021 | Molecular Diagnostics

With the new agreement, Isohelix GeneFix Saliva DNA and RNA Collection Devices are integrated into AutoGen FlexSTAR DNA extraction workflows.

Illumina, Kartos Create Oncology Partnership to Develop NGS-Based TP53 Companion Diagnostic

Apr 26, 2021 | Cancer, Molecular Diagnostics

This companion diagnostic for multiple hematologic indications will be the first to use TSO 500 with peripheral whole blood as a diagnostic sample type.

Novel Autism Saliva Test Gets Breakthrough Device Designation

Apr 19, 2021 | Molecular Diagnostics

Clarifi ASD is indicated for use in assessing the likelihood that a child has autism spectrum disorder based on RNA epigenetic biomarkers in the saliva sample.

Hologic to Acquire Molecular Diagnostic Company Mobidiag

Apr 15, 2021 | Company News, Molecular Diagnostics

Hologic has signed a definitive agreement to acquire Mobidiag, a privately held, commercial-stage Finnish-French developer of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million.

High Recovery of Top-Quality Purified RNA

Apr 15, 2021 | Molecular Diagnostics

The Chromatrap RNA Extraction kit from Porvair Sciences follows the simple procedure of sample lysis, RNA capture, washing, and elution of purified RNA.

Guardant360 CDx Test Gets ADLT Status from CMS

Apr 12, 2021 | Cancer, Molecular Diagnostics

The Guardant360 CDx test is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers.

Blood Test for Depression, Bipolar Disorder Offers Promise of Personalized Treatment

Apr 9, 2021 | Molecular Diagnostics

The study describes how the team developed a blood test, composed of RNA biomarkers, that can distinguish how severe a patient’s depression is, their risk of severe depression in the future, and their risk of future bipolar disorder.

Caris Life Sciences Launches HLA Genotype Reporting

Apr 5, 2021 | Molecular Diagnostics

Caris HLA Genotype reporting provides expanded molecular intelligence and enhanced ability to provide more individualized treatment decisions for patients.

Qlucore Releases QOE 3.7 with ChIP-seq and Biomarker Support

Mar 30, 2021 | Information Technology, Molecular Diagnostics

Qlucore QOE 3.7 includes ChIP-seq and ATAC-seq analysis support, a new biomarker workbench, and an enhanced genome browser.

Thermo Fisher Scientific Launches Applied Biosystems QuantStudio 5 Dx Real-Time PCR System for IVD Use

Mar 26, 2021 | Molecular Diagnostics

The high-performing qPCR system’s simplified, efficient workflow minimizes steps to deliver quality results in as little as 30 minutes.

Saliva Testing May Help Doctors Diagnose Concussions

Mar 25, 2021 | Cerebrovascular, Molecular Diagnostics

Doctors may soon be able to more accurately diagnose concussions by measuring the microRNA in a person’s saliva, according to a new study.

NIH Launches New Covid-19 Test Assessment Tool

Mar 23, 2021 | Covid 19, Molecular Diagnostics

New web-based platform, developed with NIH funding, will aid in monitoring emerging SARS-CoV-2 variants and the performance of diagnostic tests.

AMP Report Highlights Need for Higher Reimbursements for Molecular Professionals

Mar 19, 2021 | Lab Management, Molecular Diagnostics

Survey reveals that current payment systems do not account for all of the time qualified healthcare professionals spend to interpret and integrate results with a patient’s diagnosis.